
Journal of the American Chemical Society p. 1640 - 1649 (1991)
Update date:2022-08-04
Topics:
Gebhard, Matthew S.
Koch, Stephen A.
Millar, Michelle
Devlin, Frank J.
Stephens, Philip J.
Solomon, Edward I.
Low-temperature single-crystal magnetic circular dichroism (MCD) and polarized absorption studies were performed on an axial ferrous rubredoxin structural model complex, [Et4N]2[Fe(SR)4] (R = 2-(Ph)C6H4). This complex was found to have a dx2-y2 ground state with the dz2 orbital at 1400 cm-1. A ligand field analysis of the observed and assigned 5E → 5T2 and 5E → 3Γ transitions gives Dq = -350 cm-1, C = 2800 cm-1, and B = 620 cm-1, in contrast to ferric thiolate complexes which exhibit much larger reductions, the 70% reduction in ferrous electron repulsion parameters from the free ion values is accounted for based on standard spin restricted ligand field theory. This indicates that the inverted bonding description found for ferric complexes is not present in the ferrous complexes. Thus a large electronic relaxation takes place upon reduction which should affect redox properties of iron thiolate complexes. A calculation of the ground-state zero-field splitting based on spin-orbit coupling to the 5T2 and 3Γ ligand field excited states gives Dcalc = -8.7 cm-1 which is in excellent agreement with Dexp = -8.7 ± 0.7 cm-1 as determined from the MCD temperature dependence. The splitting of the ferrous 3d orbitals is found to depend on the interactions with the S-Feσ bonding orbital as determined by the σC orientation. This effect accounts for the ground-state differences between the model complex and ferrous rubredoxin and reveals a strong dependence of the ground state on the αC orientation.
HEZE KINGVOLT CHEMICAL CO., LTD
Contact:86-573-82118911
Address:Juancheng Industry Park
Yicheng Goto Pharmaceuticals Co.,Ltd.
Contact:+86 710 3423122
Address:5th Floor,East Gate of Building #2,Servo-Industrial Park,1st Qilin Road,Xiangyang,Hubei,China
Shenyang NovPharm Technology Co., Ltd.
Contact:.+86-24-24165786
Address:Room 306, Hongjin Mansion, No. 36-1, Wanliutang Rd., Shenhe District, Shenyang, Liaoning, P.R.C.
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Contact:+86-576-84177669, 89189665,89189688,84168770
Address:Jiangkou Development Zone, Huangyan, Taizhou City, Zhejiang
Shanxi Tongji Pharmaceuticals Co., Ltd.
Contact:+86-359-3024784
Address:Xikuang South Road, Ruicheng County , Shanxi
Doi:10.1021/jo00942a024
(1973)Doi:10.1016/j.bmcl.2011.04.117
(2011)Doi:10.1016/j.dyepig.2016.05.017
(2016)Doi:10.1071/CH9901643
(1990)Doi:10.1021/jo2009824
(2011)Doi:10.1002/chem.201100503
(2011)